Top News

ProteoGenix Gets $20M B

Portland, Oregon-based ProteoGenix, a firm which is developing genomic and high-throughput protein analytical techniques for the diagnostic testing for maternal-fetal health, has received $20M in a Series B funding. Accoridng to New Leaf Venture Partners and TPG Growth, the firms co-led the $20M Series B round in ProteoGenix. Vijay Lathi of NLV, Fred Cohen of TPG, and G. Steven Burrill of Burril and Company have joined the firm's board of directors. More information »



Related Companies:

Related Stories


blog comments powered by Disqus

Latest Headlines

Browse Issues